Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Journal of Clinical Oncology - United States
doi 10.1200/jco.2009.22.6480
Full Text
Open PDFAbstract
Available in full text
Date
September 20, 2009
Authors
Publisher
American Society of Clinical Oncology (ASCO)